These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 25890882
1. Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013. Prat J. Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):858-69. PubMed ID: 25890882 [Abstract] [Full Text] [Related]
2. Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum. Prat J, FIGO Committee on Gynecologic Oncology. Cancer; 2015 Oct 01; 121(19):3452-4. PubMed ID: 26110780 [Abstract] [Full Text] [Related]
3. The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer. Zeppernick F, Meinhold-Heerlein I. Arch Gynecol Obstet; 2014 Nov 01; 290(5):839-42. PubMed ID: 25082067 [Abstract] [Full Text] [Related]
4. Cancer of the ovary, fallopian tube, and peritoneum. Berek JS, Kehoe ST, Kumar L, Friedlander M. Int J Gynaecol Obstet; 2018 Oct 01; 143 Suppl 2():59-78. PubMed ID: 30306591 [Abstract] [Full Text] [Related]
6. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. Rosendahl M, Høgdall CK, Mosgaard BJ. Int J Gynecol Cancer; 2016 May 01; 26(4):680-7. PubMed ID: 26937751 [Abstract] [Full Text] [Related]
7. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Int J Gynaecol Obstet; 2021 Oct 01; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199 [Abstract] [Full Text] [Related]
9. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin. Morency E, Leitao MM, Soslow RA. Int J Gynecol Pathol; 2016 May 01; 35(3):222-9. PubMed ID: 26630225 [Abstract] [Full Text] [Related]
10. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study. Luyckx M, Leblanc E, Filleron T, Morice P, Darai E, Classe JM, Ferron G, Stoeckle E, Pomel C, Vinet B, Chereau E, Bergzoll C, Querleu D. Int J Gynecol Cancer; 2012 Oct 01; 22(8):1337-43. PubMed ID: 22964527 [Abstract] [Full Text] [Related]
11. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer. Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E, Ortiz-Quintana L. Int J Gynecol Cancer; 2015 Jan 01; 25(1):49-54. PubMed ID: 25405578 [Abstract] [Full Text] [Related]
12. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Meinhold-Heerlein I, Fotopoulou C, Harter P, Kurzeder C, Mustea A, Wimberger P, Hauptmann S, Sehouli J. Arch Gynecol Obstet; 2016 Apr 01; 293(4):695-700. PubMed ID: 26894303 [Abstract] [Full Text] [Related]
13. Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy? Sioulas VD, Schiavone MB, Kadouri D, Zivanovic O, Roche KL, O'Cearbhaill R, Abu-Rustum NR, Levine DA, Sonoda Y, Gardner GJ, Leitao MM, Chi DS. Gynecol Oncol; 2017 Apr 01; 145(1):15-20. PubMed ID: 28238354 [Abstract] [Full Text] [Related]
14. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum]. Šišovská I, Minář L, Felsinger M, Anton M, Bednaříková M, Hausnerová J, Jandáková E, Weinberger V. Ceska Gynekol; 2017 Apr 01; 82(3):230-236. PubMed ID: 28593778 [Abstract] [Full Text] [Related]
15. A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma. Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D. J Gynecol Oncol; 2020 Jul 01; 31(4):e45. PubMed ID: 32026659 [Abstract] [Full Text] [Related]
19. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis. Davidson W, Madan R, O'Neil M, Tawfik OW, Fan F. Ann Diagn Pathol; 2016 Jun 01; 22():54-7. PubMed ID: 27180061 [Abstract] [Full Text] [Related]
20. Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers. Matsuoka A, Tate S, Nishikimi K, Iwamoto M, Otsuka S, Shozu M. In Vivo; 2022 Jun 01; 36(5):2453-2460. PubMed ID: 36099140 [Abstract] [Full Text] [Related] Page: [Next] [New Search]